In this case, Kenneth Grom was awarded medical treatment in the form of testosterone cream therapy to counteract the decrease in his testosterone levels due to his opiate medications. The defendant, Shasta Wood Products, argued that the treatment was not necessary to cure and relieve him from the effects of his industrial injury. The Workers’ Compensation Appeals Board held that the treatment was reasonable and necessary to cure and/or relieve him from the effects of his industrial injury, and affirmed the WCJ’s determination.
Shasta Wood Products; and State Compensation Insurance Fund Kenneth Grom WORKERS’ COMPENSATION APPEALS BOARDSTATE OF CALIFORNIAKENNETH GROM, Applicant,vs.SHASTA WOOD PRODUCTS; and STATE COMPENSATION INSURANCE FUND, Defendants.Case No. RDG 0091839OPINION AND DECISION AFTER RECONSIDERATION On November 12, 2004, we granted reconsideration in this matter to provide an opportunity to further study the legal and factual issues raised by the petition for reconsideration. Having completed our review, we now issue our Decision After Reconsideration. Defendant, Shasta Wood Products, by and through its insurer, State Compensation Insurance Fund (SCIF), seeks reconsideration of the Findings, Award and Order, issued August 26, 2004, in which a workers’ compensation administrative law judge (WCJ), awarded applicant “such further medical treatment as is needed to cure and/or relieve from the effects of the industrial injury” (emphasis added), specifically allowing applicant a t
